Printer Friendly

Faster approval for some drugs.

Faster approval for some drugs

Responding to the recommendations of a presidential taskforce on regulatory relief, the Food and Drug Administration (FDA) announced last week that it would propose a change in its rules for experimental drugs so that those showing promise could be made available to terminally ill patients.

Normally, experimental drugs can be used only to treatpatients who are participating in FDA-approved clinical trials. But under the proposed change, any persons with "immediately life-threatening and other serious diseases for which no alternative therapies exist' would also be permitted treatment with these investigational drugs. Says FDA Commissioner Frank E. Young, the new policy would essentially formalize the ad hoc procedures recently used to speed the experimental drug AZT to AIDS patients (SN: 1/24/87, p.56).
COPYRIGHT 1987 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1987, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Science News
Date:Mar 21, 1987
Words:128
Previous Article:DOD revises its space policy.
Next Article:Getting the bugs out of packaging.
Topics:


Related Articles
Tax measure fails by wide margin.
Sunshine on her shoulders.
ELECTRONIC MUSIC RINGS BELL POPULARITY OF FUTURISTIC SOUNDS MOVES TO CLASSROOM.
BRIEFLY TYSON WON'T WORK IN IBRAGIMOV'S CORNER ON SATURDAY.
MS pills are making news.
Stem cells & MS: what the investigators see.
Compounded drugs are dangerous concoctions, critics say.
The Whistleblower: Confessions of a Healthcare Hitman.
Drugs just a click away: online pharmacies can make dangerous drugs easy to get, but also can promote better health care. Should we regulate them?

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters